News

YIV-906 reprograms and primes the TME (STING, IFNg, IFNb, P-IRF3) and enhances innate immunity by polarizing and increasing M1 like macrophage infiltration and enhancing apoptosis.
Yiviva Presents Phase 2b Results for YIV-906 in Combination with Sorafenib in Advanced Hepatocellular Carcinoma at ASCO and ESMO GI 2025 ...
Nicolás Pasquali, who considers himself the "first Argentine to visit every country in the world", has revealed which nation is his favourite after visiting all 195 ...
YIV-906 has been studied in nine clinical trials in solid tumors (hepatocellular carcinoma, pancreatic cancer, colorectal cancer, and rectal cancer) with data demonstrating the potential for YIV-906 ...
老哥 排序这个功能比较常用 现在每次加载完项目 都要 去 项目 设置里 根据 图片的类型 来修改排序的方向 然后 我想 ...